Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORCEPT THERAPEUTICS INCCORT · Entity 2620 | Director | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORCEPT THERAPEUTICS INC
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectJames N. Wilson and Pamela D. Wilson Trust | 1,064,543 |
Last balance in matching sequence
After 2026-09-15 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-09-15 · Sale · Disposed 6,800 · Balance 1,067,743 F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction. F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.66 to $110.64 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. F5: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Row 2 · 2026-09-15 · Sale · Disposed 400 · Balance 1,067,343 F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction. F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $110.665 to $111.095 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. F5: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Row 3 · 2026-09-15 · Sale · Disposed 2,800 · Balance 1,064,543 F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction. F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $111.70 to $111.705 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. F5: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectJames N. Wilson 2025 Grantor Retained Annuity Trust | 200,000 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 200,000 |
| Common StockSEC Table I · non-derivative | IndirectPamela D. Wilson 2025 Grantor Retained Annuity Trust | 200,000 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 200,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.
F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.66 to $110.64 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $110.665 to $111.095 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $111.70 to $111.705 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F5: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2021 Filed Apr 17, 2021 01:08 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | OtherCommon Stock | 109,483 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-016142 · doc4.xml · nonDerivative · entry 3 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust. Read SEC document |
| April 14, 2021 Filed Apr 17, 2021 01:08 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Tax withholdingCommon Stock | 90,517 | $22.95 | $2,077,365.15 |
DisclosureSEC source: 0000899243-21-016142 · doc4.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,483 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on April 14, 2021. The options subject to the net exercise were to expire on May 19, 2021. Read SEC document |
| April 14, 2021 Filed Apr 17, 2021 01:08 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 200,000 | $4.42 | $884,000.00 |
DisclosureSEC source: 0000899243-21-016142 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2021 Filed Jun 2, 2022 21:00 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020700 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,162,845 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| November 19, 2020 Filed Feb 11, 2021 22:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 253,712 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005945 · doc5.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,065,362 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| July 10, 2020 Filed Jul 17, 2020 22:17 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019563 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,319,074 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| May 27, 2020 Filed May 29, 2020 23:23 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $15.15 | $0.00 |
DisclosureSEC source: 0000899243-20-014629 · doc4.xml · derivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-05-26 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 21:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 284,218 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-19-026357 · doc4.xml · derivative · entry 5 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 284,218 shares Expires 2019-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 21:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Tax withholdingCommon Stock | 153,754 | $14.63 | $2,249,421.02 |
DisclosureSEC source: 0000899243-19-026357 · doc4.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,246 F1 · kind: The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 21:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 284,218 | $2.30 | $653,701.40 |
DisclosureSEC source: 0000899243-19-026357 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2019 Filed Jul 17, 2020 22:16 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 284,218 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-20-019562 · doc4a.xml · derivative · entry 5 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 284,218 shares Expires 2019-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| October 28, 2019 Filed Jul 17, 2020 22:16 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Tax withholdingCommon Stock | 153,712 | $14.63 | $2,248,806.56 |
DisclosureSEC source: 0000899243-20-019562 · doc4a.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,288 F1 · kind: The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares. F2 · balance_after: Reflects the adjusted number of shares following the return of 42 shares withheld in excess of the number of shares initially withheld as payment for taxes in connection with the cashless stock option exercise. Read SEC document |
| October 28, 2019 Filed Jul 17, 2020 22:16 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 284,218 | $2.30 | $653,701.40 |
DisclosureSEC source: 0000899243-20-019562 · doc4a.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 20:07 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0000899243-19-017626 · doc4.xml · derivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-06-18 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over a one-year period. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 21:18 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 105,782 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-19-007044 · doc4.xml · derivative · entry 4 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,218 Underlying: Common Stock · 105,782 shares Expires 2019-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 21:18 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 105,782 | $2.30 | $243,298.60 |
DisclosureSEC source: 0000899243-19-007044 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Mar 8, 2019 01:08 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 13,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006768 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,331,574 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:39 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0000899243-18-023080 · doc4.xml · derivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-08-20 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period. Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 22:44 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-18-019004 · doc4.xml · derivative · entry 4 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,000 Underlying: Common Stock · 10,000 shares Expires 2019-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 22:44 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 10,000 | $2.30 | $23,000.00 |
DisclosureSEC source: 0000899243-18-019004 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2018 Filed May 10, 2018 22:24 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012440 · doc4.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,345,202 F1 · balance_after: Reflects the corrected amount of shares which was previously inadvertently misstated. F2 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| March 13, 2018 Filed May 10, 2018 22:24 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 10,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-012440 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,361,202 F1 · balance_after: Reflects the corrected amount of shares which was previously inadvertently misstated. F2 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:09 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $12.13 | $0.00 |
DisclosureSEC source: 0000899243-17-014587 · doc4.xml · derivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2027-05-24 F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 24, 2017 over one-year period. Read SEC document |
| February 22, 2017 Filed Mar 8, 2017 02:39 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 49,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006773 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,409,503 Read SEC document |
| November 16, 2016 Filed Feb 14, 2017 22:59 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 112,000 | $9.46 | $1,059,520.00 |
DisclosureSEC source: 0000899243-17-004037 · doc5.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 789,067 Read SEC document |
| November 16, 2016 Filed Mar 2, 2017 23:19 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 112,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006141 · doc5a.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,459,396 Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,216 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · derivative · entry 9 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,216 shares Expires 2017-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully Exercisable. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 14,216 | $9.10 | $129,386.92 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · nonDerivative · entry 6 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 901,067 F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.91 to $9.36 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 14,216 | $1.51 | $21,466.16 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · nonDerivative · entry 5 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 915,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,216 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · derivative · entry 11 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,216 shares Expires 2017-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully Exercisable. Read SEC document |
| November 11, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 14,216 | $9.10 | $129,386.92 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · nonDerivative · entry 6 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.91 to $9.36 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| November 11, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 14,216 | $1.51 | $21,466.16 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · nonDerivative · entry 5 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 33,247 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · derivative · entry 8 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,216 Underlying: Common Stock · 33,247 shares Expires 2017-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully Exercisable. Read SEC document |
| November 10, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 33,247 | $8.90 | $295,948.17 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · nonDerivative · entry 4 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 901,067 F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.86 to $9.039 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| November 10, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 33,247 | $1.51 | $50,202.97 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · nonDerivative · entry 3 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 934,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 33,247 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · derivative · entry 10 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,216 Underlying: Common Stock · 33,247 shares Expires 2017-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully Exercisable. Read SEC document |
| November 10, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 33,247 | $8.90 | $295,948.17 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · nonDerivative · entry 4 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.86 to $9.039 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| November 10, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 33,247 | $1.51 | $50,202.97 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · nonDerivative · entry 3 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 111,349 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · derivative · entry 7 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,463 Underlying: Common Stock · 111,349 shares Expires 2017-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully Exercisable. Read SEC document |
| November 09, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 111,349 | $8.32 | $926,913.62 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 901,067 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.27 to $8.375 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| November 09, 2016 Filed Nov 15, 2016 00:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 111,349 | $1.51 | $168,136.99 |
DisclosureSEC source: 0000899243-16-033398 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,012,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 111,349 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · derivative · entry 9 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,463 Underlying: Common Stock · 111,349 shares Expires 2017-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully Exercisable. Read SEC document |
| November 09, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 111,349 | $8.32 | $926,913.62 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · nonDerivative · entry 2 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.27 to $8.375 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| November 09, 2016 Filed Mar 2, 2017 23:14 UTC Amendment | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 111,349 | $1.51 | $168,136.99 |
DisclosureSEC source: 0000899243-17-006137 · doc4a.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.